Search Press releases Keywords From To 19 Jan 2022 UCB to acquire Zogenix Read More 18 Jan 2022 Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Phase 3 Non-Radiographic Axial Spondyloarthritis Study Read More 8 Jan 2022 Disposals of own shares Read More 3 Jan 2022 Disposals of own shares Read More 21 Dec 2021 Disposals of own shares Read More 16 Dec 2021 Positive Top-Line Results for BIMZELX[®]▼(bimekizumab) in Phase 3 Ankylosing Spondylitis Trial Read More Pagination First page Previous page Previous … Page 46 Page 47 Page 48 Page 49 Current page 50 Page 51 Page 52 Page 53 Page 54 … Page 50 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
